Instrumentation
Thermo Fisher ScientificWLD-TEC
Read MoreThermo Fisher ScientificWLD-TEC
Read MoreClarient Inc announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published.
Read MoreDST Health Solutions, LLC today announced its 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations.
Read MoreCILS InternationalDolomiteVistaLab Technologies
Read MoreDetector C, an in-vitro diagnostic blood-based screening product for the early detection of colorectal cancer, has been shown to detect 90% of all colorectal cancers as well as a substantial proportion of precancerous lesions known as high-grade adenomas.
Read More